The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma. (Q45351163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

Stanley Thian Sze Wong

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Jimmy Yu Wai Chan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

29 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

126-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23686740%20AND%20SRC:MED&resulttype=core&format=json

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

State-of-the-art management of nasopharyngeal carcinoma: current and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Critical appraisal of maxillary swing approach for nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Prediction of surgical outcome using plasma Epstein-Barr virus dna and (18)F-FDG PET-CT scan in recurrent nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

New approach to the nasopharynx: the maxillary swing approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Maxillary swing approach for resection of tumors in and around the nasopharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Salvage surgery for recurrent primary nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Cancer of the nasopharynx: functional surgical salvage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Elimination of palatal fistula after the maxillary swing procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Nasopharyngectomy in the treatment of recurrent nasopharyngeal carcinoma: a twelve-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Complementary determination of Epstein-Barr virus DNA load and serum markers for nasopharyngeal carcinoma screening and early detection in individuals at risk in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Plasma Epstein-Barr virus DNA concentration and clearance rate as novel prognostic factors for metastatic nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.24193